CARE Access to Innovation Position Statement

Access Position Statement 2018.png

 Members of the CARE™ Hematology and Oncology Faculty met at ASCO (Chicago, June); EHA (Stockholm, June) and CUA (Halifax, June) to consider a CARE™ position statement regarding access to innovative therapies in Canada. These working groups were augmented with ad hoc sessions in Toronto and Hamilton for faculty who were unable to attend these sessions. 

CARE Perspectives on ASCO EHA 2018

ASCO & EHA REPORT 2018.png

Select members of the CARE™ Faculty attended the 2018 ASCO (American Society for Clinical Oncology) meeting, held in Chicago, IL from June 1st to 5th and the annual EHA (European Hematology Association) meeting held in Stockholm Sweden, June 14th to 17th. 

This report features updates from the 2018 ASCO and EHA Conferences augmented with CARE ™ Faculty Perspectives. It also provides highlights from recent CARE™ programs including multiple Needs Assessments. 

This report focuses on hematological cancers and features coverage on Multiple Myeloma, Waldenström Macroglobulinemia, Non-Hodgkin’s Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia and Stem Cell Transplant/Cell Therapy. 

Content is drawn from the ASCO/EHA 2018 meetings and is written in the language in which it was presented. 

CARE Hematology Faculty who have contributed to this report:

Dr. Kevin Song
BC Cancer Agency

Dr. Peter Anglin
Southlake Regional Health Centre

Dr. John Kuruvilla
Princess Margaret Cancer Centre

Dr. Dennis Kim
Princess Margaret Cancer Centre

CARE Perspectives on Tandem 2018

Unknown-2.jpeg

This CARE Perspectives conference report has been developed by the CARE Hematology Faculty who recently attended the 2018 Bone and Marrow Transplantation (BMT) Tandem Meetings (Tandem 2018) held in Salt Lake City, UT. Presented from a Canadian perspective, this education piece provides a summary of compelling stories and news presented at Tandem 2018 augmented by a recent publication from the European Myeloma Network (EMN).

CARE Hematology Faculty who have contributed to this report: 

John Kuruvilla, MD
Princess Margaret Cancer Centre

Dennis Kim, MD
Princess Margaret Cancer Centre


CARE Ontario Winter Hematology Update Meeting Report

ONTARIO WINTER HEMATOLOGY ASH UPDATE .png

The inaugural CARE Winter Hematology Update took place on February 23rd, 2018 at the Shangri-La Hotel in Toronto, Ontario. CARE was pleased to welcome an excellent Faculty of Canadian key opinion leaders (KOLs) with expertise in a diverse set of hematological diseases. Members of the CARE Hematology Faculty presented updates from ASH 2017 and other key hematological news framed from a Canadian perspective.

This CARE meeting featured an exciting set of presentations covering the most impactful hematological topics, along with CARE Working Group Meetings - for smaller KOL groups to have focused, extended, discussions. The CARE Working Groups focused on managing CLL, MCL, ALL, MM, and WM in Canada.

CARE (Community Academic Research Education) believes in accessibility, competition, innovation with new treatments and the optimization of current therapy- with the goal of improving patient outcomes. CARE initiatives aim to educate Canadian health care professionals by providing updates on relevant medical news and developments, framed from a Canadian perspective.


CARE Hematology Faculty who have contributed to this report:

Meeting Chairs: 

Dr. John Kuruvilla (Princess Margaret Cancer Centre)
Dr. Peter Anglin (Stronach Regional Cancer Centre)  

Presenters and Authors: 

Chronic Lymphocytic Leukemia (CLL) - Dr. Graeme Fraser (Juravinski Cancer Center) 
Hodgkin’s Lymphoma (HL) - Dr. John Kuruvilla (Princess Margaret Hospital)
Multiple Myeloma (MM) - Dr. Christine Chen (Princess Margaret Hospital)
Myeloid Disorders and Transplant  - Dr. Dennis Kim (Princess Margaret Hospital)
Non-Hodgkin’s Lymphoma (NHL) - Dr. Michael Crump (Princess Margaret Hospital)
Cell Therapy: CAR-T Focus - Dr. Ronan Foley (McMaster University)  
Emerging Concepts in Cell Therapy - Dr. Rob Laister (Princess Margaret Hospital)


CARE Management Considerations Reports

Members of the CARE Ontario Hematology Faculty held Working Group meetings in conjunction with the CARE Winter Hematology Meeting - ASH Update on February 23rd in Toronto. During these meetings relevant news and data were considered from an Ontario perspective in the areas of multiple myeloma (MM), Waldenström’s macroglobulinemia (WM), chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and acute lymphocytic leukemia (ALL). 
 

CARE Perspectives on ASH 2017

ASH 2017.png

Highlights from ASH 2017

Members of the CARE Hematology Faculty recently attended the American Society of Hematology (ASH) conference held in Atlanta, Georgia from December 9th-12th, 2017. CARE Faculty Chairs, Dr. Diego Villa and Dr. Martina Trinkaus also hosted the 12th annual CARE at ASH Resident and Trainee Education Meeting in conjunction with the conference. This was a highly successful meeting with participation from over 130 hematology professionals (residents and specialist faculty). For more information in this event and for additional CARE at ASH resources please click here.

This issue of CARE Perspectives from ASH 2017 provides a summary of the most exciting and relevant stories presented at both the American Society of Hematology conference 2017 and the CARE at ASH 2017 meeting. Abstract content is augmented with additional perspectives from select CARE at ASH presenting Faculty, including Drs. Graeme Fraser (CLL), Kevin Song (MM), Anca Prica (Lymphoma), Julie Stakiw (Leukemia), Kylie Lepic (BMT), Denis Soulières (Benign), Wendy Lim (Benign) and Christopher Patriquin (The Complement System).       

This report is written in the language which it was presented.  The content and graphics included are drawn from the respective presenters from CARE at ASH 2017.  Additional perspectives are provided by the CARE Hematology Faculty. 

CARE Perspectives on CHC 2017

CHC Report .png

The 7th annual Canadian Hematology Conference took place on September 29th and 30th, 2017 at the Shangri-La hotel in Toronto, Ontario. CARE was pleased to welcome a diverse and well reputed Faculty of over 30 Canadian and international opinion leaders who provided highly informative, cutting-edge presentations on a variety of hematological topics. 

CHC is the largest multidisciplinary hematology focused meeting in Canada and CHC 2017 was the largest to date. Two full days of presentations and symposia directed at academics, clinicians, trainees and allied health care providers (nurses and pharmacists).Content included malignant and benign hematology as wells as translational science.   

This year’s conference agenda was designed to cover the most exciting and important categories in hematology, while also providing insights and information relevant to Canadian practice. The CHC 2017 Conference Report provides a summary of the robust content presented during the CHC plenary sessions and symposia. 


Take a look at the video highlights from the event!

For more highlights from CHC 2017 click here.

CARE Oncology & Hematology Guiding Principles on Biosimilars

This initiative is led by:
John Kuruvilla, MD, Rob El-Maraghi, MD, Peter Anglin, MD, Denis Soulières, MD & Stephen Chia, MD

The CARE Faculty has been looking at the impact of biosimilars since 2015, given the significance of this topic across both chronic and disease entities. Select CARE Oncology and Hematology Faculty members have consolidated the following guiding principles based on the collective discussion from past CARE Education initiatives that explored the anticipated impact that the introduction of biosimilars will have in Canada.

Biosimilars have been a topic of interest for various CARE™ Faculties for several years now. To gauge levels of understanding along with perceptions and opinions on the impact that biosimilars will have on the Canadian landscape, a number of CARE faculties conducted needs assessments with their peers. Between 2014-2016, needs assessments were directed at specialists in gastroenterology, rheumatology, oncology, and hematology.

The aim of developing these principles is to provide Canadian health care providers with an overarching view of the positions from the CARE Faculties, which in turn may help inform their treatment decisions.

CARE Perspectives on ASCO 2017 - Hematology Focused Insights

 

Hematology Focused Insights with Content from ICML & EHA

Members of the CARE Hematology Faculty recently attended the ASCO (June 2-6, Chicago IL), ICML (June 14-17, Lugano Switzerland) and EHA (June 22-25, Madrid Spain) conferences to review the news and developments in the field of hematological malignancies.

This issue of CARE Perspectives provides a summary of the most compelling stories and news presented at these events, and is augmented with additional perspectives from the CARE Hematology Faculty. This report was developed to inform and provide guidance to the Canadian hematology community. The content that follows is written in the language in which it was presented and is adapted from the abstracts from ASCO, ICML and EHA. 

CARE believes in medical education with emphasis on: 

  • Optimization of current therapy, combinations and sequencing; 
  • Innovation with new therapy; 
  • Access to appropriate treatment

Access and innovation considerations are included within this hematology-focused report.

Please stay tuned for more CARE updates and programming. If you would like more information on our CARE programs, please contact us at info@careeducation.ca

CARE Perspectives on ASH 2016

Highlights from ASH 2016

Members of the CARE Hematology Faculty recently attended the ASH 2016 conference held in San Diego, California from December 3rd-6th, 2016. CARE Faculty Chair, Dr. John Kuruvilla also hosted the 11th annual CARE at ASH Resident and Trainee Education Meeting in conjunction with the conference. This was a highly successful meeting with participation from over 120 hematology professionals (residents and faculty specialists). For more information in this event and for additional CARE at ASH resources please visit www.CAREeducation.ca. 

This issue of CARE Perspectives from ASH 2016 provides a summary of the most exciting and relevant stories presented at the conference. Abstract content is augmented with additional perspectives from Dr. John Kuruvilla as well as select CARE at ASH presenting Faculty, including Drs. Diego Villa (CLL), Laurie Sehn (NHL), Andre Schuh (Leukemia), and Kevin Song (MM).

The content that follows is written in the language in which it was presented and is adapted from the abstracts presented during the ASH 2016 meeting. Of note, some abstracts have been updated to reflect the data presented during the oral plenary sessions at ASH.

CARE Perspectives on CHC 2016

The 6th annual Canadian Hematology Conference (CHC 2016) successfully took place on September 23rd-24th in Toronto, Ontario. We were pleased to welcome a dynamic faculty of Canadian and International KOL’s who provided cutting-edge presentations on a variety of hematological malignancies and benign disorders. 

This conference is run every year with the goal of bringing hematology professionals together to learn, network, and share experiences relating to the management of hematological disorders in Canada. This year was our largest conference yet, with over 160 academic and community specialists, residents, nurses and pharmacists in attendance. 

The CARE Perspectives Conference Report from CHC 2016 and the lunch symposia provides a summary of the most compelling stories and news presented at this event, and provides Canadian perspectives from the CARE Hematology Faculty. 

 


CHCsymposia.png

CHC 2016 Symposia

This year, three symposia were held at this event, focused in Follicular Lymphoma, Complement Disorders, and Supportive Care. We were pleased to welcome a dynamic faculty of Canadian and International KOL’s who provided cutting-edge presentations on these topics of interest.

This supplement to the CARE Perspectives: CHC 2016 provides a summary of these symposia.

CARE Perspectives on ASCO & EHA 2016

Members of the CARE Hematology Faculty recently attended the ASCO & EHA 2016 conferences held in Chicago, Illinois (June 3-7) and Copenhagen, Denmark (June 9-12). CARE was pleased to host the annual resident education meeting in conjunction with ASCO. This meeting brought together a pan-Canadian Faculty of KOLs to showcase news and developments in hematology. Presentations featured cutting edge content with discussion on relevant cases and treatment strategies. CARE at ASCO was attended by over 50 Canadian oncology professionals. Attendees included academic specialists, trainees and residents.

The content that follows is written in the language in which it was presented. The following content is drawn from the abstracts at ASCO and EHA 2016, as well as the presentation made at the CARE at ASCO 2016 meeting by Dr. John Kuruvilla. This report is augmented with content and perspectives from the CARE Hematology Faculty.

CARE Hematology Faculty Who Have Contributed to This Report:

John Kuruvilla, MD
Princess Margaret Cancer Centre

David MacDonald, MD
Dalhousie University

 

Perspectives de CARE: CCH-QC 2016

Rapport de la conférence CARE sur l’hématologie – Québec

Le programme de CARE (Communauté. Académique. Recherche. Éducation) est fier d’avoir complété cette première Conférence CARE sur l'hématologie au Québec (CCH-QC 2016), tenue le 15 avril à Montréal.

Les présentateurs chevronnés provenaient de plusieurs institutions d’enseignement et de recherches du Québec. Des sujets à la fine pointe de l’actualité, relatifs au domaine de l'hématologie, dont le lymphome, la leucémie, les troubles myéloprolifératifs, la dyscrasie plasmocytaire et des troubles bénins rares, ont été présentés.

Ce rapport résume ces présentations données par des spécialistes québécois de premier plan en hématologie. Les présidents de conférence étaient Dr. Denis-Claude Roy et Dr. Luigina Mollica, tous deux de l’Hôpital Maisonneuve-Rosemont (HMR).

La conférence CCH-QC a été préparée par le Comité académique de CARE sur l'hématologie en collaboration avec CellCAN.

Le rapport a été initialement écrit en français. Les tableaux et figures ont été insérés dans la langue choisie par chaque présentateur. 

Présidents de la conférence :

Denis-Claude Roy, MD
Hôpital Maisonneuve-Rosemont

Luigina Mollica, MD
Hôpital Maisonneuve-Rosemont

 

CARE Perspectives CCOLD 2016

Conference Report on Multiple Myeloma and Lymphoproliferative Disorders

Highlights from CCOLD 2016

Members of the CARE Hematology Faculty recently presented at the CCOLD 2016 conference held in Banff, Alberta from March 18-20. This version of CARE Perspectives provides a summary of the presentations on multiple myeloma and lymphoproliferative disorders. 

CARE Hematology Faculty who have contributed to this report:

Kevin Song, MD - BC Cancer Agency
Christopher Venner, MD - Cross Cancer Institute

 

HEMA-TIMES: Paroxysmal Nocturnal Hemoglobinuria Needs Assessment Results

Research led by Dr. Christopher Patriquin and Dr. Loree Larratt

Paroxysmal nocturnal hemoglobinuria (PNH) is an ultra-rare, and under-recognized complement-mediated disease. Because of its rarity, it is not well understood. In order to understand both current perception and knowledge of PNH with hematologists, a needs assessment was conducted. The research is being led by Dr. Christopher Patriquin (McMaster University, The Canadian PNH Network) and Dr. Loree Larratt (University of Alberta, The Canadian PNH Network). 

This needs assessment was distributed by mail and electronically to upwards of 400 Canadian hematologists working in academic teaching centres and/or community practices. The response rate to this needs assessment is 19% (n=77). What follows is an overview of the key takeaways from the needs assessment, along with the response data. 

 

Hematology Year in Review 2015

There were a number of exciting developments in Hematology this year. The Hematology Year in Review 2015 is an interactive report that covers some of the most exciting stories in the field of hematology throughout 2015. An overview of programs that different CARE faculties have developed in 2015 and upcoming conferences in 2016 have also been highlighted in this report.

 


CARE Perspectives ASH 2015

Members of the CARE Hematology Faculty recently attended the American Society of Hematology (ASH) 2015 conference held in Orlando, Florida from December 5-8. The 10th annual CARE at ASH meeting was held on Friday, December 4th and was attended by upwards of 85 trainees and specialists in the community of practice. Leading Canadian specialists spoke on a number of exciting topics in the field of hematology. 

The CARE Perspectives ASH Report provides:

  • A summary of the most compelling stories and news presented at this annual event 
  • Expert perspectives from the CARE Hematology Faculty
  • Supportive CARE considerations 
 
 


CARE Perspectives CHC 2015

CARE Education is pleased to have successfully completed the 5th annual Canadian Hematology Conference (CHC 2015), held on October 2-3 in Toronto, Ontario. 

This two day conference brings together a pan-Canadian and international Faculty of KOLs to showcase news and developments in hematological malignancies. Presentations featured cutting edge content with discussion on relevant cases and treatment strategies.

CHC 2015 is the largest multidisciplinary hematology focused meeting in Canada, attended by over 150 Canadian hematology professionals. Attendees included academic and community specialists, residents, nurses and pharmacists with an interest in hematology.

The CARE Perspectives Conference Report from CHC 2015 provides a summary of content presented by leading Canadian specialists as well as several International hematologists at the event, chaired by Drs. John Kuruvilla & Peter Anglin. 

Below is a link to the full report:

 click here for the full report

click here for the full report

 


CARE Perspectives IWCLL 2015

Members of the CARE Hematology Faculty recently attended the IWCLL 2015 conference held in Sydney, Australia (September 7-9).

The CARE Perspectives Conference Report from IWCLL 2015 provides a summary of the most compelling stories and news presented at this event, and is augmented with additional perspective from the CARE Hematology Faculty. 

 CLICK HERE TO VIEW THE FULL REPORT

CLICK HERE TO VIEW THE FULL REPORT

 

CARE Perspectives IMW 2015

Members of the CARE Hematology Faculty recently attended the 2015 International Myeloma Workshop (IMW) September 23-26 in Rome, Italy.

The CARE Perspectives Conference Report from IMW provides a summary of the most compelling stories and news presented at this event, and is augmented with additional perspectives from the CARE Hematology Faculty. 

Below is a link to the full report:

 CLICK HERE TO VIEW THE FULL REPORT

CLICK HERE TO VIEW THE FULL REPORT

 

CARE Perspectives EHA 2015

  Click here to view the full CARE Perspectives EHA 2015 Conference Report. 

Click here to view the full CARE Perspectives EHA 2015 Conference Report. 

Members of the CARE Hematology Faculty recently attended the European Hematology Association (EHA) 2015 conference held in Vienna, Austria (June 11-14).

The CARE Perspectives Conference Report from EHA provides a summary of the most compelling stories and news presented at this event, and is augmented with additional perspectives from the CARE Hematology Faculty. 

Below is a link to the full report:

  Click here for the full report.

Click here for the full report.